SCHEMBL7733819

SCHEMBL7733819

COC(=O)[C@H]1C[C@H](NC(=O)CNC(=O)OC(C)(C)C)CN1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 11/20 0.39
MMP9 P14780 1/20 0.39
ANPEP P15144 6/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
EPHX1 P07099 1/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
BTK Q06187 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTPN1 P18031 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7733529 1.00 MMP2 (0.39) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7726401 1.00 MMP2 (0.39) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7733815 1.00 MMP2 (0.39) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7726398 1.00 MMP2 (0.39) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7727967 0.89 BTK (0.40) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7726096 0.89 BTK (0.40) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7728179 0.89 BTK (0.40) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7726834 0.89 BTK (0.40) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7721954 0.89 BTK (0.40) MMP2MMP9ANPEPALDH1A1MEN1
SCHEMBL7721952 0.89 BTK (0.40) MMP2MMP9ANPEPALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed